CLIENT NEWS
- Adrenomed completes full enrollment with 300 patients in AdrenOSS-2 trial with Adrecizumab in septic shock26 September 2019
- Biocrates Life Sciences AG and Helmholtz Zentrum München Celebrate 10 Years of Partnership in Personalized Medicine25 September 2019
- APEIRON to present preclinical APN401 data at the 2019 ESMO Congress25 September 2019
- Ergomed plc: Interim results for the six months ended 30 June 201925 September 2019
- Ergomed plc: Board Change25 September 2019
- Apogenix AG: ESMO and Apogenix Collaborate on “Recurrent Glioblastoma Management: Challenges and Opportunities” Colloquium24 September 2019
- Apogenix AG: Publication in Human Vaccines & Immunotherapeutics Illustrates the Advantages of Hexavalent CD40 Agonists in Targeting CD40 in Immuno-Oncology19 September 2019
- Molecular Health to present at upcoming congresses19 September 2019
- MagForce AG to host Lunch Symposium on Local Therapies in Malignant Gliomas during the 19th European Congress of Neurosurgery (EANS2019)19 September 2019
- Verona Pharma to Present Phase 2 Data with Ensifentrine Dry Powder Inhaler Formulation in COPD at European Respiratory19 September 2019